Methotrexate Tablets — Class III drug recall D-0066-2024
Ongoing recall by West-Ward Columbus Inc, reported 2023-11-01, distributed in MS, OH. Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demon
| Recall number | D-0066-2024 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | West-Ward Columbus Inc, Columbus, OH, United States |
| Recall initiated | 2023-09-22 |
| Classified | 2023-10-23 |
| Reported by FDA | 2023-11-01 |
| Distributed | MS, OH |
| Quantity | 2,673 cartons |
| NDC | 00054-4550, 00054-4550-15, 00054-4550-25, 00054-8550, 00054-8550-25 |
| Lot numbers | AB7486B, AB8766B, AB9484B |
| Expiration dates | 2023-12-20, 2024-04-20, 2024-08-20 |
Product
Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724. NDC: 0054-8550-25
Reason for recall
Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0066-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.